K.TouyzR
doi:10.1128/MSYSTEMS.00929-24 96
Robert MacLeod, Xiaolin Luo, Alexey Revenko, You Cancer Communications .2026;[Epub] CrossRef Identification of a novel platelet-related prognostic model for hepatocellular carcinoma Hong Pan, Xi Cheng, Yong Dong, Da Li Discover Oncology .2026;[Epub] CrossRef TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study Yuhao Su, Yuxin Liang, Deyuan Zhong, Yahui Chen, Ming Wang, Qinyan Yang, Hongtao Yan, Xiaolun Huang Frontiers in Immunology .2026;[Epub] CrossRef Synthesis and Antitumor Mechanism of a Fluorescent Cyclic Peptide Selectively Targeting Integrin v3 on Hepatocellular Carcinoma Zhiqin Zhang, Lingyun Li, Xiao Liu, Siqi Wei, Huirun Yang, Ping Yang, Qing Mu Journal of Medicinal Chemistry .2026
These factors were not explored in detail in this study
The SURMOUNT trials showed average weight loss of 20 to 22 percent